Current healthcare payment systems in the United States are all plagued by the problem of adverse incentivization. A more efficient system would be one which leaves billing entities uncertain of how a given patient encounter will be reimbursed.
TO THE EDITORS:
Current payment systems in United States healthcare are plagued by the problem of adverse incentivization. Capitated systems encourage providers to underutilize resources so as to maximize profit, potentially limiting patients’ access to useful medications or procedures. Fee-for-service systems encourage providers to overutilize resources, straining an already bloated healthcare budget and perversely rewarding poor outcomes that require subsequent costly treatment. A recently proposed reimbursement system—the accountable care organization (ACO)—seeks to mitigate the magnitude of adverse incentivization by combining system-wide capitation with provider-level quality and safety benchmarks.
While ongoing efforts to simultaneously maximize healthcare quality and minimize cost are to be applauded, early experiences from ACO trial sites have yielded mixed results.1 The ACO model may be equally unable to yield an optimal balance of quality and cost as traditional reimbursement models because, like those systems it is designed to replace, it fails to directly address the economic reasoning of ground-level healthcare providers. Savvy billing entities (providers, provider networks, or entire healthcare systems) with a comprehensive understanding of any reimbursement system will utilize that understanding to maximize profit within that system. It is the a priori knowledge of the reimbursement scheme’s methodology that creates a financial incentive for either underprovision or overprovision of care.
A more efficient system, which to my knowledge has not previously been proposed, would be one which leaves billing entities uncertain of how a given patient encounter will be reimbursed until after that encounter has been concluded. In such a system, a neutral and blinded third-party organization would randomly assign closed patient encounters to either fee-for-service payment or capitated payment. Because providers would not have been cognizant of the reimbursement scheme at the time of care provision, the only incentive for providers at point of contact would have been to provide the best and most judicious possible care to the patient.
Such a system, while purely theoretical, would not be prohibitively difficult to implement, as it could be built upon existing payment schemes. The system would be highly dependent upon the existence of a neutral and trustworthy third-party organization to adjudicate claims, but the underlying relationships between payers and providers would not need to be drastically altered. Until the issue of adverse incentivization is addressed at a more fundamental level, currently envisioned payment schemes may, by design, continue to yield suboptimal outcomes.Author Affiliations: Department of Surgery, University of Colorado- Denver, Aurora, CO.
Source of Funding: None reported.
Author Disclosures: The author reports no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.
Authorship Information: Concept and design; drafting of the manuscript; critical revision of the manuscript for important intellectual content.
Address correspondence to: David Paul Kuwayama, MD, MPA, Department of Surgery, University of Colorado-Denver, 12631 E 17th Ave, Mail Stop C312, Aurora, CO 80045. E-mail: david.kuwayama@ucdenver .edu1. Centers for Medicare & Medicaid Services. Pioneer Accountable Care Organizations succeed in improving care, lowering costs. http://www.cms.gov/Newsroom/MediaReleaseDatabase/Press- Releases/2013-Press-Releases-Items/2013-07-16.html. Published July 16, 2013. Accessed October 21, 2013.
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
AI in Health Care: Closing the Revenue Cycle Gap
April 1st 2025This commentary explores the current state, challenges, and potential of artificial intelligence (AI) in health care revenue cycle management, emphasizing collaboration, data standardization, and targeted implementation to enhance adoption.
Read More
Managed Care Reflections: A Q&A With Hoangmai H. Pham, MD, MPH
April 1st 2025To mark the 30th anniversary of The American Journal of Managed Care® (AJMC®), each issue in 2025 will include a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The April issue features a conversation with Hoangmai H. Pham, MD, MPH, a member of AJMC’s editorial board and the president and CEO of the Institute for Exceptional Care (IEC).
Read More